Gluconolactone
|
Basic information |
| Metabolite name | Gluconolactone |
 | HMDB0000150 |
 |
C00198 |
 |
7027 |
| Synonyms | Gluconic acid lactone; |
| No. of studies | 9 |
|
Basic information |
| Metabolite name | Gluconolactone |
| HMDB0000150 |
|
C00198 |
|
7027 |
| Synonyms | Gluconic acid lactone; |
| No. of studies | 9 |
|
Relationship between Gluconolactone and depression (count: 9) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1090 | Type1 | CUMS group vs. control group | Plasma | BALb/c mouse | Up |
| Study M1097 | Type1 | placebo-treated depression group vs. control group | Faece | Human | Up |
| Study M1105 | Type1 | psychological stress group vs. control group | Faece | C57BL/6 J mouse | Down |
| Study M116 | Type3 | LY group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M613 | Type1 | CSDS susceptible group vs. control group | Ventral hippocampus | C57BL/6 J mouse | Down |
| Study M613 | Type1 | CSDS susceptible group vs. control group | Serum | C57BL/6 J mouse | Down |
| Study M613 | Type2 | CSDS susceptible + imipramine group vs. CSDS + vehicle group | Medial prefrontal cortex | C57BL/6 J mouse | Up |
| Study M682 | Type1 | fenvalerate-treated male offspring group vs. control male offspring group | Serum | ICR mouse | Up |
| Study M928 | Type1 | CUMS group vs. control group | Faece | C57BL/6 mouse | Down |
| Study M951 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Down |
| Study M951 | Type2 | CUMS + paeoniflorin group vs. CUMS group | Urine | Sprague-Dawley rat | Up |
| Study M981 | Type1 | Abeta oligomer group vs. control group | Serum | ICR mouse | Up |